Incidence Of Phlebitis In Patients Research Articles

METODE COACHING GROW TERHADAP PELAKSANAAN PEMASANGAN INFUS

The Use of Coaching GROW Method on Infusion. Implementation of infusion that is not in accordance with standard procedures will be at risk of phlebitis. GROW Coaching is a strategy to increase awareness in changing behavior of nurses during infusion according to standard procedures. The purpose of this study is to attempt to change nurses' behavior in infusion so as to minimize the incidence of phlebitis in patients. This study uses a quasi-experimental method (Pre-Post test with Group Design) with 34 samples of nurse implementers, namely 17 treatment groups and 17 control groups. 170 patient samples, 85 treatment groups and 85 control group patients. The results of the Wilcoxon sighed rank test-test and post-test analysis in the treatment group showed p value= 0.05, in the control group with p value= 0.3 and mann-whitney test p value= 0.01 means there is significant differences in nurses implementing between grow coaching methods and without GROW coaching. This means that the implementation of SPO based on GROW coaching has an opportunity value of fewer plebitis. The results of this study suggest that nursing managers use the GROW coaching method so that they can improve skills in changing nurses' behavior in infusion and preventing phlebitis.

KORELASI BUNDLE PHLEBITIS DENGAN KEJADIAN PHLEBITIS DI RUANG RAWAT INAP

The incidence of phlebitis in Tk.II Udayana hospital was 4.88% higher than the 2013 standard of the Indonesian Ministry of Health, which was <1.5%, even though the hospital had prepared a Phlebitis Bundle Standard Operating Procedure (SOP). This study aims to determine the correlation between bundle phlebitis and the incidence of phlebitis in the inpatient room of Tk. II Udayana. This study was a quantitative observational study with a correlational method and a cross-sectional design. The study involved 81 samples, namely patients who were treated in five inpatient rooms. Data collection nurses' compliance with SOP and the incidence of phlebitis in patients using observation sheets. Data were analyzed using Rank Spearman correlation. It was found that 45 nurses (55.6%) were obedient in carrying out the phlebitis bundle and there were 54 people (66.7%) patients who did not experience phlebitis. There was a positive correlation between bundle phlebitis and the incidence of phlebitis (p0.001 <0.05). It is recommended that the hospital provide assistance to the nurse in charge when providing intravenous infusion therapy by applying the standard operating procedure (SOP) of the phlebitis bundle.

Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial

Intravenous amiodarone is considered an effective treatment option for cardiac ventricular and atrial arrhythmias. Peripheral infusion of amiodarone may cause blood vessels irritation and phlebitis that is the most common complication of this drug by this route even when it is administered within recommended dosing limits. The effect of injection-site splinting on the occurrence of phlebitis among a group of cardiac arrhythmia patients receiving peripherally infused amiodarone. This research is a clinical trial on patients of Tehran Heart Center who were hospitalized due to cardiac arrhythmias. A sample of 60 patients with mean age 65±14years were randomly divided into control and test groups. In the experimental group with close splint and restrict the movement of the injection site until the end of the infusion and control groups without closing brace, at the same time received amiodarone. Injection protocol was similar for both groups. The results were analyzed with Spss18. The results of this research still significantly reduced the incidence of amiodarone injection-site phlebitis in the injection time (P=.005).

The Incidence of Phlebitis in Patients Receiving Amiodarone Administration

OBJECTIVE: To determine the incidence of phlebitis after amiodarone administration in Bangkok Hospital Rayong, and to study the factors affecting phlebitis in patients receiving intravenous amiodarone.MATERIALS AND METHODS: The retrospective study was conducted by reviewing patient medical records from all patients who received intravenous amiodarone during January 2011- December 2014. Concentration, type of dilute solution, duration of amiodarone therapy, peripheral intravenous size of catheter, age and underlying disease were examined. Descriptive statistics were used to analyze concentration, type of solution, duration, peripheral intravenous size of catheter, age and underlying disease. Chi - square test was used to analyze the factors affecting the phlebitis.RESULTS: In the sample of 127 patients, 16 patients had phlebitis and the incidence of phlebitis was 12.6%. Phlebitis occurred in 14.4% of patients given a concentration ≤ 2 mg/ml and 6.7% concentration more than 2 mg/ml. Depending on the size of the catheter, it was found that 32.1% of phlebitis occurred in patients who received a catheter 22-gauge (G) size and larger whereas none of the patients who received a catheter 24-G size presented with phlebitis. Regarding the duration of amiodarone administration, 35% of patients received amiodarone administered >24-48 hours and 50% of these received medication in > 48 hours while in those who received medication in ≤ 24 hours, the occurrence of phlebitis was only 7.6%. The duration of amiodarone administration was significantly associated with phlebitis.CONCLUSION:The incidence of phlebitis occurrence by amiodarone intravenous administration at peripheral entry mainly radial vein and few via cubital vein was studied, and we found that by using catheter 24-G, phlebitis will not occur, regardless of the concentration, duration and dilution (mixed with DW or NSS). The explanation for this is the faster speed of administration in catheter 24-G than the larger size of catheter resulting in the amiodarone not aggregating and combining with platelets, white blood cells and red blood cells that cause phlebitis.

Pengaruh Lama Pemasangan Infus dengan Kejadian Flebitis pada Pasien Rawat Inap di Bangsal Penyakit Dalam dan Syaraf Rumah Sakit Nur Hidayah Bantul

<p>Infusion is one invasive procedure performed in a hospital. Inpatient therapy and intravenous fluids are given continuously in the long term will increase the likelihood of complications from infusion, one of which is the occurrence of phlebitis. The purpose of this study was to determine the effect of treatment duration infusion with the incidence of phlebitis in patients on the ward and neurological disease in the Nur Hidayah hospital in Bantul. This research is an analytic observational study with cross sectional approach, the number of samples is determined by calculation slovin as many as 133 people, with the sampling technique used purposive sampling. Data results from this study showed that respondents with a longer infusion <3 days a total of 37 respondents (32.8%) who did not have phlebitis 31 respondents (10.8%) and those with phlebitis 6 respondents (26.2%). As for respondents with a longer infusion ≥3 days as many as 76 respondents (67.2%) who experienced phlebitis 74 respondents (53.8%) and who had not had phlebitis 2 respondents (22.2%). Based on the results of data analysis using chi-square test values obtained p-value of 0.000, which means the value significantly smaller than the significance level α: 0.05, it means that the research hypothesis is accepted. In conclusion, that there is a long infusion influence on the incidence of phlebitis. Therefore, it may be advisable for the health care team in a hospital for treatment of patients infusion according to the procedure, especially for patients with infusion of more than 3 days, to avoid the occurrence of phlebitis.</p>

Incidence of phlebitis in patients with peripheral intravenous catheters: The influence of some risk factors

Objective: To identify the incidence of phlebitis and the risk factors which contribute to its development in patients with peripheral intravenous catheters. Design: Prospective observational study. Setting: Medical ward of a central hospital in Portugal. Subjects: Patients with peripheral intravenous catheters hospitalised in the medical ward. Interventions: Nurses observed the peripheral intravenous (IV) catheterisation site daily. If there were complications, the catheter was replaced, and both the development of phlebitis and the procedure were recorded. Results: A total of 1,244 catheters were observed, and 317 were removed/inserted. Incidence of phlebitis was 11.09%. A multivariate analysis of risk factors for phlebitis showed patients with KCI (OR: 2.112; CI: 1.124‑3.969), who were on antibiotics (OR: 1.877; CI: 1.141‑3.088) and who had a catheter in an upper limb (OR: 0.31; CI: 0.111‑0.938) were at higher risk for phlebitis. Conclusion: Despite the patients’ profile (high mean age and high level of dependency), the risk factors are related to the use of prescribed medication and the catheterised limb. Although these findings show the development of phlebitis is not solely related to nurses’ practices, the authors believe these professionals can have an important impact on the prevention of phlebitis. The results show the accurate selection of the catheterisation site, which relies entirely on the nursing intervention, is an important factor for phlebitis.

Effect of Intrafix® SafeSet Infusion Apparatus on Phlebitis in a Neurological Intensive Care Unit: A Case-control Study

To investigate the effect of the Intrafix(®) SafeSet infusion apparatus on the incidence of phlebitis in patients being intravenously infused in a neurological intensive care unit (ICU). Patients aged > 12 years, with no history of diabetes mellitus and no existing phlebitis, requiring a daily peripheral intravenous infusion of ≥ 8 h with the total period lasting ≥ 3 days, were enrolled. Infusions were performed using the Intrafix(®) SafeSet or normal infusion apparatus. Incidence of phlebitis (scored according to the Infusion Nursing Standards of Practice of the American Infusion Nurses Society) was analysed. Patients (n = 1545) were allocated to Intrafix(®) SafeSet (n = 709) or normal infusion (n = 836) groups, matched for age, gender and preliminary diagnosis. Incidence of phlebitis was significantly higher using normal infusion apparatus compared with the Intrafix(®) SafeSet (23.4% versus 17.9%, respectively). Intrafix(®) SafeSet infusion apparatus significantly reduced the incidence of phlebitis in patients in the neurological ICU, compared with normal infusion apparatus, and may be suitable for use in routine clinical practice.

Study on incidence of phlebitis in patients with PICC through peripheral vein and its nursing effect

Objective To observe the incidence of phlebitis in patients with PICC through peripheral vein and its nursing effect, in order to aLleviate the patients' suffering. Methods The 60 volunteers were divided into three groups randomly, who were received PICC through basilie vein, vena mediana and cephalic vein, the incidence of of phlebitis and therapeutic effieaey were analyzed. Results 2 patients appeared phlebitis in 20 cases received PICC through basilic vein, 3 patients in 20 eases through eubital vein, and all cured;11 patients in 20 eases through cephalic vein, while 9 patients were cured and 2 patients were detubated in cephalic vein group. Conclusions It' s suggested that the prevalence of phlebitis with PICC through cephalic vein is high, with long treat time and low cure rate. It' s likely to reduce the phlebitis occurrence and patients relief from pain through eephalic vein. Key words: PICC; Peripheral vein; Phlebitis

Flebitis relacionada con la administración intravenosa de antibióticos macrólidos. Estudio comparativo de eritromicina y claritromicina

To know and to compare the incidence of phlebitis due to intravenous administration of macrolide antibiotics erythromycin and clarithromycin. Non-randomized prospective study of consecutive patients who were diagnosed of community pneumonia and treated with intravenous macrolides (19 with erythromycin and 25 with clarithromycin). The cumulative incidence of phlebitis in patients treated with erythromycin was 78.9% (incidence rate of 0.40 episodes/patient-day) and in those treated with clarithromycin 76% (incidence rate of 0.35 episodes/patient-day). The risk of phlebitis is high and similar with intravenous administration of both macrolides.